Serious Risks: More significant concerns involve insulin resistance, acromegaly (abnormal tissue overgrowth), and the potential for tumor development in individuals with existing predispositions
Brodska H et al (2015) Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium
The Phase 3 TRIUMPH program will determine whether, and at what doses, retatrutide reaches the market
Three key genetic regions include GLP1R (appetite and glucose sensing), FTO (metabolic adaptation and fat mass), and MC4R (energy expenditure and satiety)
Semenova E, Koegel H, Hasse S, Klatte JE, Slonimsky E, Bilbao D
Readers are encouraged to consult original publications, regulatory documentation, and qualified healthcare professionals before making decisions related to patient care, research, or healthcare policy